GIP/GLP-1 dual receptor agonist
Tirzepatide in Australia: prescription, brands, pricing
This page summarises the situation of Tirzepatide in Australia under TGA (Therapeutic Goods Administration): prescription status, available brands and generics, pharmacy dispensing, and online options in AUD. Tirzepatide belongs to the GIP/GLP-1 dual receptor agonist class.
- Regulator
- TGA (Therapeutic Goods Administration)
- Currency
- AUD
About Tirzepatide
Tirzepatide is approved in adults with type 2 diabetes mellitus, as monotherapy or in combination with other antidiabetic agents, to improve glycaemic control. Australia's medications are scheduled S1 through S10; Schedule 4 (prescription only) and Schedule 8 (controlled drugs) require written or e-prescriptions. The Pharmaceutical Benefits Scheme (PBS) subsidises most prescription costs to a fixed patient co-payment.
Mechanism and action
Tirzepatide binds with high affinity to the GIP receptor and to the GLP-1 receptor.
Brands and generics in Australia
In Australia, Tirzepatide is typically dispensed as one internationally recognised brand along with their corresponding authorised generics. Australian pharmacies (Chemist Warehouse, Priceline Pharmacy, TerryWhite Chemmart and many independents) are regulated state-by-state. Pharmacist consultation is a core part of dispensing, with several states allowing pharmacists to prescribe for minor ailments under structured programmes. Brand-to-generic substitution is decided by the pharmacist under local TGA (Therapeutic Goods Administration) equivalence rules, and the price difference in AUD is usually substantial.
Online and tele-prescribing access
Online prescription dispensing in Australia operates through TGA-registered pharmacies and tele-prescribing platforms that have expanded since 2020. Personal importation of prescription medication is allowed under limited conditions for genuine personal use under the TGA's Personal Importation Scheme. For Tirzepatide specifically, the legal online options in Australia depend on its Rx-or-OTC classification under TGA (Therapeutic Goods Administration).
Frequently asked questions
Is Tirzepatide available in Australia? ▾
Yes — Tirzepatide and its brands are available in Australia through pharmacies authorised by TGA (Therapeutic Goods Administration), in various strengths depending on the commercial product. Authorised generics offer a lower-cost alternative with the same active substance.
Do I need a prescription for Tirzepatide in Australia? ▾
Australia's medications are scheduled S1 through S10; Schedule 4 (prescription only) and Schedule 8 (controlled drugs) require written or e-prescriptions. The Pharmaceutical Benefits Scheme (PBS) subsidises most prescription costs to a fixed patient co-payment. The exact status of Tirzepatide (Rx or OTC) is determined by TGA (Therapeutic Goods Administration); most active ingredients in the GIP/GLP-1 dual receptor agonist class require prescription, although there are exceptions by country and formulation.
How much does Tirzepatide cost in Australia? ▾
The price in AUD depends on the manufacturer (brand vs authorised generic), the strength and the pack size. Generics are typically substantially cheaper than brands and serve as the economic reference for ongoing use.
Products with Tirzepatide in Australia
Tirzepatide in other countries
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.